Probiotics: prospects for therapeutic use in inflammatory intestinal diseases
- Authors: Rumyantsev VG1, Rumyantsev VG1
-
Affiliations:
- Issue: No 13 (2009)
- Pages: 77-79
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/277472
- ID: 277472
Cite item
Full Text
Abstract
The paper discusses the prospects for probiotics use for the prevention of exacerbations and treatment of inflammatory bowel disease (IBD) - ulcerative colitis and Crohn's disease. We present current data on the intestinal microflora and its physiological functions, as well as the role of intestinal flora in the genesis of inflammation in IBD. We give a probiotics characteristics, discuses the results of probiotics clinical trials in IBD. It is concluded that management of IBD by probiotics is a simple, natural and safe therapeutic intervention. These clinical studies suggest that the probiotics use should be long-term - one year continuously, or in the form of repeated courses, required in large doses.
References
- Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis 2004;10:286-99.
- Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004;126:1620-33.
- Seksik P, Sokol H, Lepage P, et al. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther 2006;24:11-18.
- Reid G. Safe and efficacious probiotics: what are they? Trends Microbiol 2006;14:348-52.
- Vanderpool C, Yan F, Brent Polk D. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 2008;14:1585-96.
- Isaacs K, Herfarth H. Role of probiotic therapy in IBD. Inflamm Bowel Dis 2008;14:1597-605.
- Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-94.
- Guarner F. What is the role of the enteric commensal flora in IBD? Inflamm Bowel Dis 2008;14(Suppl. 2):83-88.
- Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 2009;136:65-80.
- Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 2009;136:2015-31.
Supplementary files
